Copy number profiling of circulating free DNA predicts transarterial chemoembolization response in advanced hepatocellular carcinoma

Transarterial chemoembolization (TACE) is the most commonly used treatment for advanced hepatocellular carcinoma (HCC), but still lacks accurate real‐time biomarkers for monitoring its therapeutic efficacy. Here, we explored whether copy number profiling of circulating free DNA (cfDNA) could be util...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Xiuqing, Chen, Geng, Huang, Xinghui, Li, Zhenli, Peng, Fang, Chen, Hengkai, Zhou, Yang, He, Lei, Qiu, Liman, Cai, Zhixiong, Liu, Jingfeng, Liu, Xiaolong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120881/
https://www.ncbi.nlm.nih.gov/pubmed/34939323
http://dx.doi.org/10.1002/1878-0261.13170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120881/
https://www.ncbi.nlm.nih.gov/pubmed/34939323
http://dx.doi.org/10.1002/1878-0261.13170

Ejemplares similares